Vaxart, Inc.

NASDAQ:VXRT

Biotechnology

Healthcare
$0.53 -1.75%

-$0.01 today

Market cap
$129.30M
Beta
1.09
P/E (TTM)
3.6
EPS (TTM)
$0.15
52W Low $0.26High $0.84

Volume 0.12M

Average 0.41M

Income Statement

Follow revenue through to earnings.

Revenue

$237.26M

FY 2025 · Annual

+726.7% YoY

Operating Income

$18.07M

FY 2025 · Annual

Net Income

$16.33M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue892K107K7.38M28.7M237.26M
Cost of Revenue48.75M04.5M00
Gross Profit(47.86M)107K2.88M28.7M237.26M
Gross Margin-5365.1%100.0%39.0%100.0%100.0%
Research & Development48.75M81.05M68.14M74.21M201.58M
Selling, General & Admin21.89M29.39M22.58M20.78M17.61M
Operating Expenses24.9M114.69M86.23M94.99M219.18M
Depreciation & Amortization2.43M5.81M8.62M8.85M8.58M
EBITDA(66.45M)(100.58M)(72.13M)(54.87M)28.21M
EBITDA Margin-7449.7%-94000.9%-977.5%-191.2%11.9%
Operating Income(72.75M)(114.59M)(83.35M)(66.29M)18.07M
Operating Margin-8156.1%-107090.7%-1129.5%-231.0%7.6%
Interest Income81K1.25M2.65M2.54M1.6M
Interest Expense1.48M1.31M1.45M2.97M2.82M
Other Income / Expenses2.39M6.9M1.14M(395K)(1.27M)
Income Before Tax(70.36M)(107.69M)(82.2M)(66.69M)16.8M
Pre-Tax Margin-7888.2%-100645.8%-1114.0%-232.4%7.1%
Income Tax Expense107K67K261K260K476K
Net Income(70.47M)(107.76M)(82.47M)(66.95M)16.33M
Net Margin-7900.2%-100708.4%-1117.6%-233.3%6.9%
EPS (Basic)(0.14)(0.22)(0.17)(0.14)0.07
EPS (Diluted)(0.14)(0.22)(0.17)(0.14)0.07
Weighted Avg Shares487.26M487.26M487.26M487.26M230.27M
Weighted Avg Shares (Diluted)487.26M487.26M487.26M487.26M230.35M

VXRT Earnings Waterfall · TTM

NASDAQ:VXRT · Revenue to Net Income

Key Ratios

EPS$0.14
Gross Margin100.0%
Net Margin4.3%
P/E Ratio0.8
P/S Ratio2.1

Analysis

$255.6M of revenue converted into $37.1M of net income for the selected period. Gross margin is 100.0% and net margin is 4.3%, showing how much revenue survives after costs and taxes. EPS is $0.14, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
DEFA14ADEFA14A filingJul 2, 2026
8-KCurrent reportJul 2, 2026
DFAN14ADFAN14A filingJul 2, 2026
DEFA14ADEFA14A filingJul 1, 2026
8-KCurrent reportJun 26, 2026

How much revenue does VXRT generate?

Vaxart, Inc. (VXRT) reported $237.26M of revenue in fiscal 2025.

Is VXRT profitable?

Vaxart, Inc. (VXRT) reported $16.33M of net income, with a net margin of 6.9%.